Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Viking Aktie: Phase-3-Pläne


Viking Therapeutics will sein orales Adipositas-Medikament VK2735 noch in diesem Jahr in die Phase…

Der Beitrag Viking Aktie: Phase-3-Pläne erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Viking Therapeutics Inc Stock

€29.85
-1.000%
Viking Therapeutics Inc shows a slight decrease today, losing -€0.300 (-1.000%) compared to yesterday.


Comments